Boys Sexual Health
NCT07915180, Not applicable, Completed, Kaohsiung Medical University Chung-Ho Memorial Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Boys Sexual Health | ClinicalTrials.gov |
| NCT number | NCT07915180 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 174 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital | ClinicalTrials.gov |
| Conditions | Sexual Health, Sexual Consent, Intervention Effectiveness, Mobile Application, Serious Games | ClinicalTrials.gov |
| Interventions | Boy's serious game | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sexual knowledge | Time Frame: baseline , immediately after the 6-week intervention, and 4 weeks post-intervention | The Adolescent Sexual Knowledge Scale, developed by the Hsing-Ling Medical Foundation, was used to assess sexual knowledge among college students. The scale consists of 12 true-or-false items covering two dimensions: pregnancy and contraception, and prevention of human immunodeficiency virus infection, acquired immunodeficiency syndrome, and other sexually transmitted infections. For the pregnancy and contraception dimension, item difficulty ranged from 0.44 to 0.48, and item discrimination exceeded 0.80. For the dimension concerning prevention of human immunodeficiency virus infection, acquired immunodeficiency syndrome, and other sexually transmitted infections, item difficulty ranged from 0.39 to 0.48, and item discrimination exceeded 0.80. These results indicate good item discrimination across the scale. | ClinicalTrials.gov |
| Primary | Sexual Consent | Time Frame: baseline , immediately after the 6-week intervention, and 4 weeks post-intervention | The Sexual Consent Scale-Revised, which is based on the theory of planned behavior, includes five subscales: perceived behavioral control (11 items; Cronbach's alpha = .86), positive attitudes toward establishing consent (11 items; Cronbach's alpha = .84), indirect consent behaviors (6 items; Cronbach's alpha = .78), sexual consent norms (7 items; Cronbach's alpha = .67), and sexual consent awareness (4 items; Cronbach's alpha = .71). The scale consists of 39 items, each rated on a seven-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate more positive attitudes toward and greater endorsement of sexual consent and negotiation behaviors in intimate relationships with heterosexual partners. | ClinicalTrials.gov |
| Primary | Safer sex | Time Frame: baseline , immediately after the 6-week intervention, and 4 weeks post-intervention | The Safer Sexual Behavior Scale was used to assess variables from the theory of planned behavior, including attitudes, subjective norms, perceived behavioral control, behavioral intentions, and behaviors, across four sexual behaviors. The scale consists of 60 items, each scored from 1 to 7. Three of the four sexual behaviors concern the use of contraception, condoms, and dual protection during sexual intercourse with an intimate partner, with higher scores indicating greater endorsement of safer sexual behaviors. The fourth concerns sexual intercourse with a casual partner, with higher scores indicating greater endorsement of casual sexual intercourse. Cronbach's alpha coefficients for the Chinese version ranged from .71 to .97. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)